Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 16.70
-0.10 (-0.60%)
At close: Apr 24, 2026
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 257.18 million as of April 24, 2026. Its market cap has decreased by -15.23% in one year.
Market Cap
257.18M
Enterprise Value
84.48M
Revenue
177.36M
Ranking
n/a
PE Ratio
17.77
Stock Price
16.70
Market Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 257.18M, a decrease of -65.35%. That is a compound annual growth rate of -14.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 257.18M | -6.18% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCI GENE | 1.01B |
| NatureWise Biotech & Medicals | 897.75M |
| MegaPro Biomedical | 799.30M |
| Neith | 793.51M |
| BioLASCO Taiwan | 755.55M |
| SynCore Biotechnology Co.,Ltd | 698.02M |
| TaiwanJ Pharmaceuticals | 657.80M |
| Vectorite Biomedical | 650.00M |